维普中文期刊产品整合服务
60篇 您的检索式:作者名="HAMBLETON J"
    题名 作者 年代 出处 被引量
1Combined analysis of Efficacy: The addition of bevacizumab to fluorouracil/ leucovorin improves survinal for patient with metastatic colorectat cancer显示文摘KABBINAVAR FF HAMBLETON J MASS RD 2005J Clin Oncol2005,23,16:1
2Global estimates of diabetes prevalence for 2013 and projections for 2035显示文摘Guariguata L Whiting D R Hambleton I Beagley J Linnenkamp U Shaw J E 2014Diabetes Res Clin Pract2014,103,:1
3Combined analysis of ef- ficacy: the addition of bevacizumab to fluoronracil/leucovorin improves survival for patients with metastatic colorectal cancer显示文摘Kabbinavar F Hambleton J Mass R D 2005J Gin Oncol2005,23,16:1
4Clostridium botulinum tox- ins: nature and preparation for elinical use 显示文摘Melling J Hambleton P Shone C C 1988Eye1988,2,1:1
5Combined analysis of efficacy:the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer显示文摘Kabbinavar FF Hambleton J Mass RD 2005J Clin Oncol2005,23,16:1
6Treatment outcomes by tumor his- tology in Eastern Cooperative Group(ECOG) study FA599 of bevaci- zumab( BV ) with paclitaxel/carboplatin ( PC ) for advanced non-small cell lung cancer ( NSCLC ) 显示文摘Sandier A Yi J Hambleton J 2008J Thorac Oncol2008,3,4:1
7A perturbation method for optimization of rigid block mechanisms in the kinematic method of limit analysis显示文摘HAMBLETON J P SLOAN S W 2013Computers and Geotechnics2013,48,:1
8RBCs treated with helinxTM pathogen inactivation show comparable recovery and survival to standard[RBCs in a randomized crossover trial显示文摘Wages DS Hambleton J Viale M 0,,:1
9A Perturbation Method for Optimization of Rigid Block Mechanisms in the Kinematic Method of Limit Analysis 显示文摘HAMBLETON J P SLOAN S W 2013Computers and Geoteehnics2013,48,1:1
10Combined analysis of efficacy :the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer显示文摘Kabbinavar FF Hambleton J Mass RJ 2005J Clin Oncol2005,23,:1
11Combined analysis of efficacy:the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer显示文摘Kabbinavar FF Hambleton J Mass RD 2005J Clin Oncol2005,23,16:1
12Combined Analysis of Efficacy:The addition of bevacizumab to fluorouracil/leucovorin improves survinal for patients with metastatic colorectal cancer显示文摘kabbinavar FF Hambleton J Mass RD 2005J Clin Oncol2005,23,14:1
13Combined analysis of efficacy: the addition of bevacizurnab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer显示文摘KABBINAVAR F F HAMBLETON J MASS R D 2005J Clin Oncol2005,23,16:1
14A 50kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botuli- num type A neurotoxin forms channels in lipid vesicles显示文摘Shone C C Hambleton P Melling J 1987Eur J Biochem1987,167,:1
15Combined analysis of effi- cacy:the addition of bevacizumab to lmpv survival for patients with metastatic coloreetal cancer显示文摘Kabbinavar FF Hambleton J Mass RD 2005J Clin Oncol2005,23,16:1
16Influence of interac- tions on water and aroma permeabilities of iota-carrageenan-oleic acid- beeswax films used for flavour encapsulation显示文摘FABRA M J HAMBLETON A TALENTS P 2009Carbohydrate Polymers2009,76,2:1
17Industrial scale production of hydrogen from natural gas, naphtha and coal显示文摘Balthasar W Hambleton D J 1980International Journal of Hydrogen Energy1980,5,:1
18Combined analysis of efficacy:the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer显示文摘Kabbinavar F F Hambleton J Mass R D 2005J Clin Oncol2005,23,16:1
19Viability of red cells prepared with S-303 pathogen inactivation treatment显示文摘Rios JA Hambleton J Viele M 2006Transfusion2006,46,10:1
20Combined analysis of efficacy:The addition of bevacizumab to fluorouracil/leucovorin imptoves survival for patients with metastatic colorectal cancer显示文摘Kabbinavar FF Hambleton J Mass RD 2005J Clin Oncol2005,23,16:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费